Skip to main content
. 2013 Mar 18;23(5):565–573. doi: 10.1111/bpa.12043

Figure 2.

figure

Pediatric high‐grade astrocytomas patients have similar overall survival with and without PDGFRA amplification. A. Pediatric patients with glioblastoma (GBM) with (n = 13) and without (n = 16) PDGFRA amplification have no significant difference in overall survival based on Kaplan–Meier survival analysis, P = 0.97. B. Kaplan–Meier survival analysis examining overall survival for pediatric patients with anaplastic astrocytoma with (n = 9) and without (n = 25) amplification of PDGFRA, P = 0.21. AA = anaplastic astrocytoma.